|
|
Volumn 8, Issue 3, 1999, Pages 333-334
|
|
Angiotensin converting enzyme inhibitors: First line therapy in patients with diabetic hypertension?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FUROSEMIDE;
LISINOPRIL;
METHYLDOPA;
NIFEDIPINE;
PRAZOSIN;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE REGULATION;
DIABETES MELLITUS;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
HYPERTENSION;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CLINICAL TRIALS;
DIABETES MELLITUS;
DIABETIC NEPHROPATHIES;
HUMANS;
HYPERTENSION;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0032809731
PISSN: 10624821
EISSN: None
Source Type: Journal
DOI: 10.1097/00041552-199905000-00009 Document Type: Editorial |
|
Times cited : (2)
|
|
References (8)
|
